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ed November 26, 2013.he aim of this study was to determine whether coronary high-intensity plaques (HIPs) visualized by noncontrast
T1-weighted imaging can predict future coronary events.Background Coronary HIPs are associated with characteristics of vulnerable plaques, including positive remodeling, lower
Hounsﬁeld units, and ultrasound attenuation. However, it remains unclear whether the presence of HIPs is
associated with increased risk for coronary events.Methods The signal intensity of coronary plaques was prospectively examined in 568 patients with suspected or known
coronary artery disease (CAD) who underwent noncontrast T1-weighted imaging to determine the plaque-to-
myocardium signal intensity ratio (PMR).Results During the follow-up period (median 55 months), coronary events were observed in 55 patients. Receiver-operating
characteristic curve analysis identiﬁed a PMR of 1.4 as the optimal cutoff for predicting prognosis. Multivariate Cox
regression analysis identiﬁed the presence of plaques with PMRs 1.4 as the signiﬁcant independent predictor of
coronary events (hazard ratio: 3.96; 95% conﬁdence interval: 1.92 to 8.17; p < 0.001) compared with the presence
of CAD (hazard ratio: 3.56; 95% conﬁdence interval: 1.76 to 7.20; p < 0.001) and other traditional risk factors.
Among the 4 groups based on PMR cutoff and the presence of CAD, coronary event–free survival was lowest in the
group with PMRs 1.4 and CAD and highest in the group with PMRs <1.4 but no CAD. Importantly, the group with
PMRs 1.4 and no CAD had an intermediate rate of coronary events, similar to the group with PMRs <1.4 and CAD.Conclusions HIPs identiﬁed in a noninvasive, quantitative manner are signiﬁcantly associated with coronary events and may thus
represent a novel predictive factor. (J Am Coll Cardiol 2014;63:989–99) ª 2014 by the American College of
Cardiology FoundationRecently, T1-weighted imaging (T1WI) of coronary plaques
with or without contrast enhancement using cardiac mag-
netic resonance (CMR) has been successfully demonstrated
(1–4). Because magnetic resonance (MR) imaging generates
images without ionizing radiation, it can be repeated
sequentially over time. Moreover, MR imaging allows theular Medicine, National Cerebral and Cardio-
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13; revised manuscript received November 8,characterization of plaque composition in addition to mor-
phologic evaluation (5). We have previously shown that the
presence of coronary high-intensity plaques (HIPs) detected
by noncontrast T1WI is associated with positive coronary
artery remodeling, low density on computed tomographic
angiography (CTA), and ultrasound attenuation (6). InSee page 1000addition, HIPs can be uniquely assessed using the plaque-
to-myocardium signal intensity ratio (PMR) (6). Although
our previous ﬁndings suggest that coronary HIPs may
represent vulnerable lesions, there have been no studies
evaluating the relationship between HIPs and subsequent
coronary events. Therefore, we designed a prospective study
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990to determine the prognostic sig-
niﬁcance of HIPs and to identify
the optimal PMR cutoff value for
predicting coronary events.
Methods
Patients. BetweenDecember 2006
and September 2010, a total of
650 consecutive patients with sus-
pected or known coronary artery
disease (CAD) were initially
screened with CTA and then
underwent CMR examinations.
Proven CAD was deﬁned as: 1) a
history of myocardial infarction
(MI) or percutaneous coronary
intervention (PCI); 2) ischemia-
proven angina pectoris or silent
myocardial ischemia diagnosed
with stress myocardial scintig-
raphy; or 3) coronary arteriog-
raphy–proven coronary artery
stenosis 50%. We excluded pa-
tients with acute MIs (n ¼ 13),
unstable angina pectoris (UAP)
(n ¼ 7), left ventricular dysfunc-tion (ejection fraction <40%) (n ¼ 4), scheduled coronary
artery bypass grafting (n ¼ 1) or PCI (n ¼ 29), and CMR
images of poor quality (n ¼ 28). Thus, 82 patients were
excluded, and a total of 568 patients (mean age 62 10 years;
435 men, 133 women) were ultimately enrolled in this study.
This study was approved by the institutional review board of
the National Cerebral and Cardiovascular Center and the
ethics committee of Shin-Koga Hospital.
Coronary CTA. Coronary CTA was performed using a
LightSpeed VCT (GE Healthcare, Milwaukee, Wisconsin).
Computed tomographic procedures used in this study have
been described previously (6).
CMR coronary plaque imaging. CMR imaging consisted
of MR angiography and T1WI of plaque using a commer-
cially available 1.5-T MR imager (Intera, Philips Medical
Systems, Best, the Netherlands) with 5-element cardiac
coils. The procedures used to acquire MR images in
this study have been previously described (6). Brieﬂy, cor-
onary plaque images were obtained using a 3-dimensional
T1-weighted turbo ﬁeld echo sequence with inversion re-
covery (inversion time delay 500 ms) and fat suppression
(repetition time 4.7 ms, echo time 1.37 ms, ﬂip angle 20,
sensitivity encoding factor 2.5, number of signals acquired
2, navigator gating window 1.5 to 2.5 mm, ﬁeld of
view 300  270  112 mm, acquisition matrices 224 
200, acquisition slice number 70, reconstruction matrices
512  512, reconstruction slice number 140, acquired
spatial resolution 1.34  1.35  1.60 mm, reconstructed to
0.59  0.53  0.80 mm). The mean acquisition time was15  3 min for plaque imaging. The average navigator
efﬁciency was 50.5%.
Plaque analysis on CMR. On CMR images, the coronary
vascular tree was subdivided into 8 segments (3). For seg-
ment identiﬁcation, segments were pre-deﬁned according
to the distance from the vessel origin. The right coronary
artery was analyzed in 3 segments (segments 1, 2, and 3).
The left coronary artery was analyzed as the left main, left
anterior descending (segments 6 and 7), and circumﬂex
(segments 11 and 13) arteries. To conﬁrm that the location
of an observed HIP (Fig. 1A) corresponded to the presence
of a coronary plaque, we used both cross-sectional (Fig. 1B)
and curved multiplanar reformation computed tomographic
angiographic images. In addition, for plaque detection, we
used coregistration images (Fig. 1C) to facilitate conﬁrma-
tion of the anatomical position of high-intensity lesions on
T1-weighted images (Fig. 1A) and the coronary vessel on
MR angiography (Fig. 1D) using commercially available
software (Virtual Place Raijin workstation, AZE, Tokyo,
Japan).
The methods used to evaluate plaque images have been
described previously (6). Brieﬂy, an experienced technician
and a cardiologist both blinded to patient data used the
T1-weighted images to calculate the PMR, deﬁned as the
signal intensity of the coronary plaque divided by that of
nearby left ventricular myocardium, measured using a free-
hand region of interest on a standard console of the clin-
ical MR system. We used left ventricular myocardium
located the same distance from the surface coil as the plaque
to determine plaque signal intensity. To avoid abnormal
myocardial T1 measurements, we did not use areas of MI for
reference. The highest signal intensity detected in each
plaque was considered the PMR value for that plaque in
segment-based analysis. In patient-based analysis, the
highest PMR among the coronary plaques was assigned to
be the PMR for that subject.
Intraclass correlation coefﬁcients with 95% conﬁdence
intervals (CIs) were calculated to assess intrareader and in-
terreader agreement for PMR. The intrareader intraclass
correlation coefﬁcient was 0.94 (95% CI: 0.80 to 0.98). The
inter-reader intraclass correlation coefﬁcient was 0.88 (95%
CI: 0.73 to 0.95). All correlation coefﬁcients for PMR were
>0.8, with narrow CIs, indicating good intraobserver and
interobserver agreement.
Follow-up study. After CMR data were obtained, study
patients were followed at 3, 6, and 12 months and annually
thereafter until the occurrence of 1 of the following coronary
events: cardiac death, nonfatal ST-segment elevation MI,
high-sensitivity cardiac troponin T (cTnT)–positive UAP or
non–ST-segment elevation MI, or ischemia-driven PCI due
to progressive angina pectoris. Cardiac death was deﬁned as
sudden death and death caused by acute MI or ventricular
arrhythmias. Elevation of cTnT was deﬁned as more than
2 times the upper limit of the normal range (0.010 ng/ml).
Myocardial ischemia was diagnosed using stress myocardial
scintigraphy before PCI. PCI-related restenosis and PCI
Figure 1 Representative Images of High-Intensity Plaques on CMR
The high-intensity signal on T1-weighted imaging (T1WI) (A) corresponds to the coronary plaque deﬁned by computed tomographic angiography (CTA) (B). Magnetic resonance
images of coronary plaque (yellow arrow) in the proximal left anterior descending coronary artery coregistered (C) with noncontrast T1W1 (A) and magnetic resonance
angiography (MRA) (D) showing that a high-intensity signal on T1WI (A) corresponds to the coronary artery wall on MRA (D).
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991due to silent myocardial ischemia were not considered cor-
onary events. Independent attending cardiologists reviewed
charts to determine if hospitalizations and deaths qualiﬁed as
coronary events. Chart review was blinded with respect to
the patient’s HIP status.
Statistical analysis. Continuous, normally distributed
baseline variables are expressed as mean  SD and were
compared using unpaired Student t tests. Categorical base-
line variables were compared using Fisher exact tests or chi-
square tests as appropriate. Analysis of variance was used to
compare the means of the 3 groups on the basis of PMR.
For any statistically signiﬁcant differences, post-hoc pairwise
comparisons for each pair were performed using the Tukey-
Kramer test for continuous variables to determine which pair
differed signiﬁcantly. PMR cutoff values were determined
on the basis of receiver-operating characteristic (ROC) curve
analysis using the Youden index. Survival analysis was car-
ried out using the Kaplan-Meier method with the log-rank
test according to the PMR cutoff value. The data were
analyzed initially using a univariate model to determine
which risk factors had signiﬁcant associations with futurecoronary events. For all variables, we assessed the assump-
tion of proportional hazards by testing for a nonzero slope in
a regression of scaled Schoenfeld residuals on time. We then
evaluated the discriminatory ability of predictors by
comparing the C-index for PMR with the C-indexes for
other clinical risk factors using Newson’s method (7).
Multivariate Cox regression analysis was then performed
using only the covariates that signiﬁcantly predicted coro-
nary events in the univariate analysis. Collinearity was
evaluated using the correlation coefﬁcients between all
covariates. Stepwise selection with a p value of 0.10 for
backward elimination was used to select the best predictive
model. Analyses were conducted using SPSS (SPSS Japan
Inc., Tokyo, Japan) and Stata version 12 (StataCorp LP,
College Station, Texas). All p values <0.05 were considered
statistically signiﬁcant.Results
PMR cutoff value for developing cardiac events. During
a median follow-up period of 55 months (interquartile
Table 1 Comparison of the Clinical Proﬁles of Patients With or Without Coronary Events
Variable Coronary Event (n ¼ 55) No Coronary Event (n ¼ 513) p Value
Age (yrs) 68  10 61  10 <0.001
Men 51 (93%) 384 (75%) 0.002
Hypertension 38 (69%) 242 (47%) 0.003
Current smokers 28 (51%) 278 (54%) 0.67
Hyperlipidemia 41 (75%) 261 (51%) 0.001
Diabetes mellitus 23 (43%) 124 (23%) 0.009
BMI (kg/m2) 23  3 24  11 0.39
SBP (mm Hg) 141  20 133  18 0.012
Total cholesterol (mg/dl) 190  42 203  34 0.006
LDL (mg/dl) 108  32 117  28 0.018
HDL (mg/dl) 49  14 55  14 0.01
TG (mg/dl) 134 (95–204) 110 (74–164) 0.01
HbA1c (%) 6.6  2 5.7  1 <0.001
PMR 1.49 (1.27–1.90) 0.94 (0.83–1.29) <0.001
PMR >1.0 51 (93%) 202 (39%) <0.001
Proven CAD 38 (69%) 105 (20%) <0.001
Multivessel disease 18 (33%) 50 (10%) <0.001
Previous MI 10 (18%) 18 (4%) <0.001
Medications
Aspirin 29 (53%) 97 (19%) <0.001
Beta-blockers 10 (18%) 29 (6%) 0.002
Statins 21 (38%) 95 (19%) 0.001
ACE inhibitors or ARBs 26 (47%) 127 (25%) 0.001
Values are mean  SD, n (%), or median (interquartile range).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin II receptor blocker; BMI ¼ body mass index; CAD ¼ coronary artery disease; HbA1c ¼
glycosylated hemoglobin; HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein; MI ¼ myocardial infarction; PMR ¼ plaque-to-myocardium
signal intensity ratio; SBP ¼ systolic blood pressure; TG ¼ triglycerides.
Figure 2 ROC Curve Analysis for Developing Coronary Events and Flowchart of Study Patients on the Basis of PMR
(A) From receiver-operating characteristic (ROC) curve analysis, a plaque-to-myocardium signal intensity ratio (PMR) of 1.4 was identiﬁed as the best cutoff value for predicting
cardiac events, with 69.5% sensitivity and 82.3% speciﬁcity. The calculated area under the curve (AUC) was 0.83. (B) To stratify the analysis of coronary events, the 568
enrolled patients were divided into the following 3 groups: PMR 1.4 (n ¼ 159), PMR 1.0 to 1.4 (n ¼ 131), and PMR <1.0 or no plaque (n ¼ 278).
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Figure 3 Representative Images of HIPs With PMRs 1.4
Representative noncontrast T1-weighted images of high-intensity plaques (HIPs) (yellow arrowheads) in the proximal left anterior descending coronary artery (A) and the right
coronary artery (C), in which plaque-to-myocardium signal intensity ratios (PMRs) were 1.91 and 2.05, respectively. These high-intensity signals each correspond to the left and
right coronary plaques on computed tomographic angiography (CTA) (yellow arrowheads on curved multiplanar reformation images, B and D). T1WI ¼ T1-weighted imaging.
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993range: 45 to 65 months), coronary events were observed in
55 of 568 study patients. Table 1 compares the clinical
proﬁles of patients with and without subsequent develop-
ment of coronary events; these groups differed signiﬁcantly
in terms of age, sex, hypertension, hyperlipidemia, diabetes
mellitus, systolic blood pressure, lipid proﬁle, glycosylated
hemoglobin, multivessel CAD, previous MI, and medica-
tion use (p < 0.05). PMRs were signiﬁcantly higher in
patients who developed coronary events than those who did
not (median 1.49 vs. 0.94; p < 0.001). Indeed, a higher
proportion of patients with coronary events had PMRs >1.0
than those without (p < 0.001).
Based on ROC curve analysis, the optimal PMR cutoff
value for developing cardiac events was 1.40, and the area
under the ROC curve was 0.83 (Fig. 2A). At this value, the
sensitivity and speciﬁcity for predicting a cardiac event were
69.5% and 82.3%, respectively.Patient-based analysis. Because coronary plaque areas with
PMRs >1.0 have been deﬁned as HIPs in previous studies
(6), we divided the study patients into 3 groups according to
the new PMR cutoff value and the previous deﬁnition as
follows: PMR 1.4 (n ¼ 159), PMR 1.0 to 1.4 (n ¼ 131),
and PMR <1.0 or no plaque (n ¼ 278) (Fig. 2B). Repre-
sentative cases of plaques with PMRs 1.4 are shown in
Figures 3A to 3D. Patients in the group with PMRs <1.0
either had coronary plaques without high-intensity signals or
no plaques on CTA. Of the 159 patients with PMRs 1.4,
41 (25.8%) developed coronary events, whereas 11 events
(8.4%) occurred in the group with PMRs of 1.0 to 1.4 (n ¼
131). Only 3 of the 278 patients (1.1%) with PMRs <1.0
developed coronary events.
Table 2 shows the baseline clinical characteristics of the 3
study groups. The group with PMRs 1.4 had a signiﬁ-
cantly higher mean age; higher proportions of men, current
Table 2 Comparison of Patients Characteristics Categorized by PMR Values
Variable
PMR 1.4
(n ¼ 159)
PMR 1.0 to 1.4
(n ¼ 131)
PMR <1.0 or No Plaque
(n ¼ 278) p Value
Age (yrs) 66  9 62  10 59  10 <0.001
Men 139 (87%) 97 (74%) 199 (72%) 0.001
Hypertension 106 (67%) 80 (61%) 95 (34%) <0.001
Current smokers 98 (61%) 58 (45%) 152 (54%) 0.015
Hyperlipidemia 99 (62%) 75 (58%) 128 (46%) 0.002
Diabetes mellitus 57 (36%) 54 (41%) 36 (13%) <0.001
BMI (kg/m2) 23.8  3 23.7  3 24.4  15 0.28
SBP (mm Hg) 138  19 138  19 130  16 0.001
Total cholesterol (mg/dl) 192  35 202  32 205  35 0.003
LDL (mg/dl) 112  28 116  28 118  30 0.18
HDL (mg/dl) 50  12 53  14 57  15 <0.001
TG (mg/dl) 147  89 157  123 118  76 <0.001
HbA1c (%) 6.0  1.3 6.1  1.5 5.6  0.5 <0.001
PMR 1.75  0.53 1.15  0.10 0.86  0.05 <0.001
Proven CAD 78 (49%) 42 (32%) 23 (8%) <0.001
Multivessel disease 46 (29%) 21 (16%) 1 (0.4%) <0.001
Previous MI 17 (11%) 7 (5%) 4 (1%) <0.001
Medications
Aspirin 58 (36%) 44 (34%) 24 (9%) <0.001
Beta-blockers 17 (11%) 12 (9%) 10 (4%) 0.01
Statins 50 (31%) 24 (18%) 42 (15%) <0.001
ACE inhibitors or ARBs 69 (43%) 41 (31%) 43 (15%) <0.001
Values are mean  SD or n (%).
Abbreviations as in Table 1.
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CAD, and previous MIs; and a lower mean level of high-
density lipoprotein cholesterol. In contrast, the level of to-
tal cholesterol was lower in the group with PMRs 1.4,
which also had higher rates of aspirin, beta-blocker, statin,
angiotensin-converting enzyme inhibitor, and angiotensin II
receptor blocker use. The median, 25th percentile, and 75th
percentile PMR values were 1.56, 1.41, and 1.88, respec-
tively, in the group with PMRs 1.4; 1.15, 1.07, and 1.21,
respectively, in the group with PMRs of 1.0 to 1.4; and 0.83,
0.81, and 0.92, respectively, in the group with PMRs <1.0.
Table 3 summarizes the coronary events that occurred
during the follow-up period. The group with PMRs 1.4
had the highest incidence of all coronary events and acuteTable 3 Coronary Events During the Follow-Up Pe
Variable
PMR 1.4
(n ¼ 159)
PMR 1
(n ¼
Composite endpoint
All coronary events 41 (25.8%) 11 (
ACS-related events 24 (15.1%) 5 (
Coronary events
Cardiac death 1 (0.6%)
STEMI 9 (5.7%) 1 (
cTnT-positive UAP/NSTEM 14 (8.8%) 4 (
Ischemia-driven PCI 17 (10.7%) 6 (
Values are n (%). ACS-related events include cardiac death, STEMI, and cTn
ACS ¼ acute coronary syndrome; cTnT ¼ cardiac troponin T; NSTEMI, n
coronary intervention; PMR ¼ plaque-to-myocardium signal intensity ratio;
angina pectoris.coronary syndrome (ACS)–related events among the
3 groups (p < 0.001).
Univariate analysis of coronary risk factors, medications,
and CMR analysis showed that age, male sex, systolic blood
pressure, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, triglycerides, glycosylated hemoglo-
bin, medications, multivessel CAD, previous MI, proven
CAD, and the presence of plaques with PMRs 1.4 were all
signiﬁcant predictors of all coronary events (Table 4). All
variables satisﬁed the assumption of proportionality. Table 5
summarizes the C-indexes of PMR and other risk factors.
PMR had the highest C-index (0.81; 95% CI: 0.76 to 0.85),
which was signiﬁcantly different from those of the other risk
factors evaluated. For the selection of the best predictiveriod
.0 to 1.4
131)
PMR <1.0 or No Plaque
(n ¼ 278) p Value
8.4%) 3 (1.1%) <0.001
3.8%) 1 (0.4%) <0.001
0 0 0.280
0.8%) 0 <0.001
3.1%) 1 (0.4%) <0.001
4.6%) 2 (0.7%) <0.001
T-positive UAP or NSTEMI.
on–ST-segment elevation myocardial infarction; PCI ¼ percutaneous
STEMI ¼ ST-segment elevation myocardial infarction; UAP ¼ unstable
Table 4
Univariate Cox Regression Analysis of Risk Factors for
All Coronary Events
Variable
Univariate Analysis
Hazard Ratio p Value 95% CI
Age 1.07 <0.001 1.04–1.10
Male 2.69 0.022 1.15–6.27
Hypertension 2.44 0.002 1.37–4.32
Current smoking 0.84 0.517 0.49–1.43
Hyperlipidemia 2.70 0.001 1.47–4.96
Diabetes mellitus 2.29 0.002 1.34–3.92
BMI, kg/m2 0.96 0.367 0.88–1.05
SBP 1.02 0.003 1.01–1.03
Total cholesterol 0.99 0.004 0.98–1.00
LDL 0.99 0.020 0.98–1.00
HDL 0.97 0.006 0.95–0.99
TG 1.00 0.001 1.00–1.00
HbA1c 1.36 <0.001 1.20–1.54
PMR 2.70 <0.001 2.09–3.48
PMR 1.4 8.28 <0.001 4.56–15.00
Proven CAD 7.70 <0.001 4.34–13.70
Multivessel CAD 4.18 <0.001 2.37–7.36
Previous MI 5.06 <0.001 2.54–10.10
Medications
Aspirin 4.57 <0.001 2.68–7.80
Beta-blockers 3.35 0.001 1.69–6.65
Statins 2.63 0.001 1.52–4.53
ACE inhibitors or ARBs 2.71 <0.001 1.59–4.61
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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995model, we started with the full model with all of the sig-
niﬁcant variables in Table 4. Age, male sex, glycosylated
hemoglobin, proven CAD, and the presence of plaques with
PMRs 1.4 remained in the ﬁnal model. The presence of
plaques with PMRs 1.4 in the coronary tree was found to
be the most signiﬁcant independent predictor for future
coronary events (hazard ratio: 3.96; 95% CI: 1.92 to 8.17;
p < 0.001) compared with proven CAD (hazard ratio: 3.56;
95% CI: 1.76 to 7.20; p < 0.001) (Table 5). Importantly,
when we focused on ACS-related events (cardiac death,
ST-segment elevation MI, and cTnT-positive UAP or non–
ST-segment elevation MI), the presence of plaques withTable 5
C-Index Analysis Demonstrating Discrimination for
Prediction of All Coronary Events
Variable C-Index 95% CI p Values
PMR 1.4 0.81 0.76–0.85 Reference
Proven CAD 0.73 0.67–0.79 0.035
Multivessel disease 0.61 0.55–0.67 <0.001
Previous MI 0.57 0.52–0.62 <0.001
Age 0.67 0.60–0.74 <0.001
Male 0.52 0.50–0.54 <0.001
BMI 0.55 0.47–0.63 <0.001
LDL 0.60 0.52–0.68 <0.001
HDL 0.61 0.52–0.69 <0.001
TG 0.59 0.51–0.68 <0.001
HbA1c 0.65 0.58–0.73 <0.001
SBP 0.59 0.51–0.67 <0.001
Abbreviations as in Tables 1 and 4.PMRs 1.4 remained a signiﬁcant independent predictor
(hazard ratio: 8.93; 95% CI: 3.23 to 24.7; p < 0.001). No
collinearity was observed among the variables in the initial
model.
Because multivariate analysis for all coronary events
showed that the presence of plaques with PMR 1.4 and
proven CAD were both signiﬁcant independent prognostic
factors (Table 6), we subdivided the study patients into the
following 4 groups according to the PMR cutoff value and
the presence or absence of proven CAD: PMR 1.4 with
CAD (n ¼ 74), PMR 1.4 without CAD (n ¼ 85),
PMR <1.4 with CAD (n ¼ 69), and PMR <1.4 without
CAD (n ¼ 340). On the basis of Kaplan-Meier analysis, the
coronary event–free survival rate was lowest in the group
with PMRs 1.4 with CAD and highest in the group with
PMRs <1.4 without CAD. The rate in the group with
PMRs 1.4 without CAD was intermediate but comparable
with that in the group with PMRs <1.4 with CAD (Fig. 4).
In addition, among patients without CAD, those with
plaques with PMRs 1.4 had worse event-free survival than
patients with plaques with PMRs <1.4 (p ¼ 0.021).
Furthermore, when we performed Kaplan-Meier analysis for
ACS-related events, patients with PMRs 1.4 showed
worse event-free survival than those with PMRs <1.4
(p < 0.001 by the log-rank test).
Segment-based analysis. Of the 4,544 segments (568
subjects) analyzed, 202 segments were excluded because they
either contained lesions scheduled for PCI or they were
previously treated with PCI using stents, leaving 4,342
segments that were analyzed (Fig. 5). Plaques with
PMRs 1.4 were identiﬁed in 207 segments, those with
PMRs of 1.0 to 1.4 were observed in 301 segments, and
those with PMRs <1.0 or no plaque was seen in 3,834
segments. Of the 207 segments with plaques with
PMRs 1.4, 35 (16.9%) segments were associated with
coronary events, which developed in 18 segments (51.4%) in
the ﬁrst 12 months and in 9 segments (25.7%) during
months 13 to 24. After 24 months, 8 of 35 segments
(22.9%) were associated with coronary events. Among pa-
tients who had coronary events during the ﬁrst 12 months,
months 13 to 24, and after 24 months, there were signiﬁcant
differences in the median, 25th percentile, and 75th
percentile PMR values (12 months: 2.23, 1.72, and 2.64;Table 6
Best Predictive Model Selected by Stepwise
Cox Regression Analysis of Risk Factors for
All Coronary Events
Variable
Multivariate Analysis
Hazard Ratio p Value 95% CI
Age 1.04 0.023 1.01–1.07
Male 2.61 0.071 0.92–7.39
HbA1c 1.04 0.018 1.03–1.36
Proven CAD 3.56 <0.001 1.76–7.20
PMR 1.4 3.96 <0.001 1.92–8.17
Abbreviations as in Tables 1 and 4.
Figure 4 Kaplan-Meier Curves Comparing the Probability of All Coronary Events
Coronary event–free survival was worst in the group with plaque-to-myocardium signal intensity ratios (PMRs) 1.4 and coronary artery disease (CAD) (red line) and best in the
group with PMRs <1.4 but no CAD group (orange line). The rate in the group with PMRs 1.4 and no CAD (green line) was intermediate but comparable with that in the group
with PMRs <1.4 and CAD (blue line).
Figure 5 Incidence of Coronary Events in Segment-Based Analysis
A total of 4,342 segments were analyzed and divided into the following 3 groups: 207 segments with plaque-to-myocardium signal intensity ratios (PMRs) 1.4, 301 segments
with plaques with PMRs of 1.0 to 1.4, and 3,834 segments with plaques with PMRs <1.0 or no plaque. Of the 207 segments with plaques with PMRs 1.4, 35 segments
(16.9%) were associated with coronary events, which developed in 18 segments (51.4%) during the ﬁrst 12 months, in 9 segments (25.7%) during months 13 to 24, and in
8 segments (22.9%) after 24 months of follow-up. PCI ¼ percutaneous coronary intervention.
Noguchi et al. JACC Vol. 63, No. 10, 2014
CMR Plaque Imaging Predicts Coronary Events March 18, 2014:989–99
996
Figure 6
PMR Values and the Timing of Coronary Events in
35 Segments With Plaques With PMRs 1.4
Results are expressed as box-and-whisker plots; the central box covers the
interquartile range, with the median indicated by the line within the box. The
whiskers extend to the most extreme values within 1.5 interquartile range. More
extreme values are plotted individually. PMR ¼ plaque-to-myocardium signal
intensity ratio.
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99713 to 24 months: 1.55, 1.42, and 1.63; >24 months: 1.69,
1.43, and 1.72; p < 0.001) (Fig. 6).
Figure 7 shows the event rates of coronary segments
stratiﬁed by the PMR cutoff value of 1.4. In coronary seg-
ments with plaques with PMRs 1.4, 16.9% of all coronary
events (35 of 207 segments) and 11.1% of ACS-related events
(23 of 207 segments) developed from the same segment as the
one containing a plaquewith a PMR1.4, whereas 0.5%of all
coronary events (5 of 1,065 segments) and 0.3% of ACS-
related events (3 of 1,065 segments) developed from seg-
ments containing plaques with PMRs <1.4 (p < 0.001,
respectively). Similarly, event rates for ST-segment elevation
MI, cTnT-positive UAP or non–ST-segment elevation MI,
and ischemia-driven PCI arising from the same segment as
the one containing a plaque with a PMR 1.4 were signiﬁ-
cantly higher than those from segments without plaques with
PMRs1.4 (p< 0.001). Thus, a higher incidence of coronary
events occurred when the culprit lesion was in the same cor-
onary segment as a plaque with a PMR 1.4.
Discussion
The major ﬁnding of this study is that the presence of plaques
with PMRs 1.4 visualized by noncontrast T1WI is a sig-
niﬁcant and independent predictor of future coronary events
in patients with CAD. To the best of our knowledge, this is
the ﬁrst clinical study that demonstrates HIP as a novel
prognostic marker identiﬁed in a noninvasive and quantitative
manner that does not involve radiation exposure.
Progress of HIP assessment in coronary arteries.
Atherosclerotic plaque imaging using MR was originally
developed for cerebrovascular disease. The presence of ahigh–signal intensity lesion on T1WI was considered to
indicate intraplaque hemorrhage (8–10) and to be associated
with a recent cerebrovascular event (9–12).
In contrast to carotid MR plaque imaging, coronary
plaque imaging with CMR has been challenging because of
the small sizes of coronary arteries, as well as cardiac and
respiratory motion. Fayad et al. (13) were the ﬁrst to
demonstrate the feasibility of coronary plaque imaging in
humans in vivo. In addition, Botnar et al. (14) and Stuber
et al. (15) have described high-resolution coronary plaque
imaging during free breathing using the combination of a
real-time navigator for respiratory gating and real-time slice-
position correction. We systematically evaluated the com-
ponents of HIPs detected by noncontrast T1WI using CTA
and intravascular ultrasound in a recent study showing that
coronary HIPs are associated with ultrasound attenuation,
positive vascular remodeling, and low computed tomo-
graphic density (6).
Assessment of HIPs and ROC curve analysis. We
assessed HIPs by calculating PMR, deﬁned as the signal
intensity of the coronary plaque divided by that of neigh-
boring left ventricular myocardium. In the previous study,
we deﬁned plaque areas with PMRs >1.0 as positive for
HIP (6). Using this deﬁnition, the prevalence of HIPs was
60% to 70% in patients with stable angina pectoris and
UAP, as reported in our previous study and others (6,16). In
the present study, the median PMRs for patients with and
without cardiac events were signiﬁcantly different: 1.49 and
0.94, respectively (Table 1). The prevalence of PMR >1.0
was 93% in patients with cardiac events, but it should be
noted that the prevalence of PMR >1.0 was also high (39%)
in those without cardiac events. Therefore, we sought to re-
evaluate the optimal PMR value for predicting coronary
events. On ROC curve analysis, a PMR of 1.4 was identiﬁed
as the best cutoff value for predicting prognosis. The
sensitivity and speciﬁcity were 69.5% and 82.3%, respec-
tively, fairly comparable with the use of the CTA index for
detecting vulnerable plaques (17). Also, in the stratiﬁed
analysis using PMR values of 1.0 and 1.4, the incidence of
cardiac events was well differentiated, 25.8% for PMR 1.4,
8.4% for PMR of 1.0 to 1.4, and 1.1% for PMR <1.0
(Fig. 2B). These rates are comparable with those in patients
with vulnerable coronary plaques detected by CTA (17).
Moreover, we calculated the C-index for PMR 1.4 and
other classic coronary risk factors. The C-index for
PMR 1.4 was 0.81, higher than for any other risk factor
(Table 5). Therefore, the new cutoff value for PMR in this
study may be clinically useful for identifying vulnerable
coronary plaques associated with future cardiac events.
The prognostic impact of HIP and its potential to detect
plaque vulnerability. Multivariate analysis for all coronary
events showed that the presence of plaques with PMRs 1.4
and proven CAD were both signiﬁcant independent prog-
nostic factors (Table 6). Therefore, we divided study patients
into 4 groups according to high and low PMRs in patients
with and without CAD. The coronary event–free survival
Figure 7 Comparisons of Event Rates Between Coronary Segments With and Without Plaques With PMRs 1.4
In the 1,272 coronary segments of 159 patients with plaques with plaque-to-myocardium signal intensity ratios (PMRs) 1.4, 207 segments contained plaques with
PMRs 1.4, and the remaining 1,065 segments contained plaques with PMRs <1.4 or no plaque. The event rate for all coronary events was 16.9% (35 of 207 segments), and
the acute coronary syndrome (ACS)–related event rate was 11.1% (23 of 207 segments) for events arising from the same segment as the one containing a plaque with a
PMRs 1.4 (blue bars), whereas 0.5% (5 of 1,065 segments) of all coronary events and 0.3% (3 of 1,065 segments) of ACS events arose from segments containing plaques
with PMRs <1.4 (p < 0.001, respectively) (red bars). Similarly, event rates for ST-segment elevation myocardial infarction (STEMI), cardiac troponin T (cTnT)–positive unstable
angina pectoris (UAP) or non–ST-segment elevation myocardial infarction (NSTEMI), and ischemia-driven percutaneous coronary intervention (PCI) developing from the same
segment as a plaque with a PMR 1.4 were signiﬁcantly higher than event rates in segments with plaques with PMRs <1.4 (p < 0.001, respectively).
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and highest in the group with PMRs <1.4 but no CAD
(Fig. 4). Importantly, the rate in the group with PMRs 1.4
and no CAD was intermediate but comparable with that in
the group with PMRs <1.4 and CAD (Fig. 4). These
ﬁndings demonstrate that coronary events can develop even
when organic stenosis is not evident, conﬁrming the concept
of vulnerable patients in whom plaque destabilization occurs
at multiple sites throughout systemic vascular beds (18,19).
Indeed, as shown in Table 2, patients with plaques with
PMRs 1.4 were characterized as a clinically high-risk
population, with higher proportions of current smokers
and patients with hyperlipidemia, proven CAD, multivessel
CAD, previous MI, and low high-density lipoprotein
cholesterol. Therefore, our results suggest that once a patient
is identiﬁed to be at high risk for having an adverse cardiacevent on the basis of traditional clinical and biochemical risk
proﬁles, noncontrast T1WI may help identify those at
greater risk for coronary events.
In addition to patient-based analysis, we also performed
segment-based analysis, indicating that segments with
especially high PMRs (median 2.23) developed coronary
events within the ﬁrst year of follow-up. Thus, such seg-
ments seem to be highly associated with disease vulnerability
(Fig. 6). Figure 7 also shows that the prevalence of coronary
events was higher in coronary artery segments with plaques
with PMRs 1.4 than in segments with plaques with
PMRs <1.4. Therefore, HIPs with high PMRs are likely to
represent vulnerable plaques that develop into culprit lesions.
CMR imaging–based evaluation of coronary plaques
described herein provides clinically important information
on the vulnerability of atherosclerotic coronary plaques.
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999Study limitations. First, this was a single-center study with
a relatively small number of patients examined, and few
reached the primary end point. A larger number of events is
needed for adequate statistical power to fully evaluate
whether a novel risk marker contributes additional prog-
nostic information to an established set of risk factors in a
multivariate model, as opposed to simply indicating whether
the new marker is prognostic by itself (20). Therefore,
although our data show that the presence of HIPs and a
PMR 1.4 are risk factors for coronary events, the relative
importance of HIPs and this PMR cutoff compared with
other cardiac risk factors should be conﬁrmed in a larger
prospective study.
Second, during the follow-up period, medical therapy
after diagnosis was individualized at the discretion of each
attending physician on the basis of symptoms and risk fac-
tors. This may be relevant to the group with PMRs 1.4,
which had a higher incidence of coronary events despite
lower total plasma cholesterol levels than the other 2 groups.
Because the group with PMRs 1.4 had higher rates of
hyperlipidemia and proven CAD, it had a higher rate of
statin use. Therefore, although HIPs may be associated with
hyperlipidemia, the prognostic impact of HIPs may be due
to more than the total cholesterol level.
Third, the results from the stepwise selection process were
potentially biased by overﬁtting the derivation dataset.
However, because the PMR cutoff value of 1.4 has been
validated using a separate validation dataset (n ¼ 175)
(Online Appendix), we consider that the PMR cutoff value
of 1.4 has been validated as a signiﬁcant risk factor for
coronary events.
Finally, although CMR is considered a safe alternative to
ionizing radiation–based imaging techniques, Fiechter et al.
(21) reported deoxyribonucleic acid double-strand breaks in
human lymphocytes induced by routine 1.5-T CMR ex-
amination. Further studies are needed to evaluate the health
risks associated with MR techniques.
Conclusions
The present study demonstrates that HIPs identiﬁed by
noncontrast T1WI are signiﬁcantly associated with coronary
events and may thus be a promising predictive factor in
patients at high risk.
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